Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Abstract
Increased generation of reactive oxygen species (ROS) and an altered redox status have long been observed in cancer cells, and recent studies suggest that this biochemical property of cancer cells can be exploited for therapeutic benefits. Cancer cells in advanced stage tumours frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacological ROS insults. However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance. Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications. We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, available data suggest that MGF-driven restoration of redox homeostasis represents a central mechanistic axis of its antitumor activity, rather than merely a downstream branch of apoptosis (84,85).”
From Mangiferin in human disease: Multifaceted mechanisms and applications (Review) (2026) · cites this paper as [84]
In the citing paper
“Activation of oncogenes, aberrant metabolism, mitochondrial dysfunction, and loss of the tumor suppressor p53 can all promote increased ROS accumulation in cancer cells 69.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [69]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379 · cited 1×
“It has been observed that a small subpopulation of primary cancer cells expressing stem-cell markers was resistant to certain chemotherapeutic agents and radiatio”
BackgroundSchafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587 · cited 1×
“A moderate increase in ROS can promote cell proliferation and differentiatio”
BackgroundFive-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488 · cited 1×
“By exploiting the genetic differences between normal cells and cancer cells, several molecular-targeted drugs, such as imatinib (Gleevec; Novartis) and trastuzumab (Herceptin; Genentech/Roche), show promising therapeutic activity and few toxic side effect”
BackgroundCancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429 · cited 1×
“Redox status in cancer stem cells Recurrence of cancer after chemotherapy or radiotherapy is initiated by a subpopulation of residual malignant cells that are highly resistant to treatment and which are believed to be cancer-initiating cells or cancer stem cell”
Background(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 3,007
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555 · cited 1×
“Recent studies showed that normal haemopoietic stem cells and normal mammary epithelial stem cells maintained ROS at lower levels than their mature progeny to prevent cellular differentiation and maintain long-term self-renewa”
BackgroundBjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272 · cited 1×
“This is consistent with the high incidence of p53 mutation or loss of p53 function in over 50% of human cancer”
Background
Research works printed but not linked: 1
- Kim, G. J., Chandrasekaran, K. & Morgan, W. F. Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review. Mutagenesis 21, 361–367 (2006). · DOI · Paper page
Cited by
Items 101–200 of 1,014
Chamoto, K., Chowdhury, P. S., Kumar, A., Sonomura, K., Matsuda, F., Fagarasan, S., & Honjo, T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620433114 · Cited by 413
“Because exogenous ROS or its generators are known to directly damage tumor cells (27), we first tested whether a ROS generator alone exhibits tumor-killing activity.”
BackgroundSystems analysis of intracellular pH vulnerabilities for cancer therapy
Persi, E., Duran-Frigola, M., Damaghi, M., Roush, W. R., Aloy, P., Cleveland, J. L., Gillies, R. J., & Ruppin, E. (2018) · Nature Communications · doi:10.1038/s41467-018-05261-x · Cited by 406
Understanding of ROS-Inducing Strategy in Anticancer Therapy
Kim, S. J., Kim, H. S., & Seo, Y. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5381692 · Cited by 406
“Adaptation to excessive ROS conditions in cancer cells has been reported, suggesting they have a higher level of antioxidative capacity and ROS than normal cells [2].”
BackgroundCorrelation between Oxidative Stress, Nutrition, and Cancer Initiation
Saha, S. K., Lee, S. B., Won, J., Choi, H. Y., Kim, K., Yang, G.-M., Dayem, A. A., & Cho, S.-G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071544 · Cited by 399
“Several studies have assessed ROS levels and generation under numerous conditions with the aim of determining when ROS are carcinogenic and when they are cancer suppressive [259].”
BackgroundReactive Oxygen Species in Normal and Tumor Stem Cells
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-420117-0.00001-3 · Cited by 403
A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
Cojoc, M., Mäbert, K., Muders, M. H., & Dubrovska, A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.06.004 · Cited by 393
Liby, K. T., & Sporn, M. B. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004846 · Cited by 405
“This approach could exploit the altered levels of oxidative stress in tumor cells versus normal cells for therapeutic benefit (Trachootham et al., 2006, 2009; Acharya et al., 2010; Montero and Jassem, 2011).”
BackgroundStimuli-Responsive Polymersomes for Biomedical Applications
Hu, X., Zhang, Y., Xie, Z., Jing, X., Bellotti, A., & Gu, Z. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.6b01704 · Cited by 394
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Labrie, M., Brugge, J. S., Mills, G. B., & Zervantonakis, I. K. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00454-5 · Cited by 369
Designing nanozymes for in vivo applications
Zhang, R., Jiang, B., Fan, K., Gao, L., & Yan, X. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00205-1 · Cited by 360
Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.
Lachaier, E., Louandre, C., Godin, C., Saidak, Z., Baert, M., Diouf, M., Chauffert, B., & Galmiche, A. (2014) · PubMed · Cited by 477
Mitochondria: Central Organelles for Melatonin′s Antioxidant and Anti-Aging Actions
Reiter, R., Tan, D., Rosales-Corral, S., Galano, A., Zhou, X., & Xu, B. (2018) · Molecules · doi:10.3390/molecules23020509 · Cited by 393
“Finally, ROS and free radicals are sometimes produced in abundance in cancer tissues that aid in the killing of these disease-causing cells [9].”
BackgroundKuehne, A., Emmert, H., Soehle, J., Winnefeld, M., Fischer, F., Wenck, H., Gallinat, S., Terstegen, L., Lucius, R., Hildebrand, J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.017 · Cited by 383
CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis
Wang, Y.-N., Zeng, Z.-L., Lu, J., Wang, Y., Liu, Z.-X., He, M.-M., Zhao, Q., Wang, Z.-X., Li, T., Lu, Y.-X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0384-z · Cited by 380
Self-citationActivatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy
Zhou, Z., Song, J., Tian, R., Yang, Z., Yu, G., Lin, L., Zhang, G., Fan, W., Zhang, F., Niu, G., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201701181 · Cited by 387
The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer
Alves-Fernandes, D. K., & Jasiulionis, M. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133153 · Cited by 385
Modulating Glycolysis to Improve Cancer Therapy
Chelakkot, C., Chelakkot, V. S., Shin, Y., & Song, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032606 · Cited by 374
Local generation of hydrogen for enhanced photothermal therapy
Zhao, P., Jin, Z., Chen, Q., Yang, T., Chen, D., Meng, J., Lu, X., Gu, Z., & He, Q. (2018) · Nature Communications · doi:10.1038/s41467-018-06630-2 · Cited by 379
Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery
Kooiman, K., Roovers, S., Langeveld, S. A. G., Kleven, R. T., Dewitte, H., O'Reilly, M. A., Escoffre, J.-M., Bouakaz, A., Verweij, M. D., Hynynen, K., et al. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.01.002 · Cited by 359
Oxidative Stress in the Regulation of Normal and Neoplastic Hematopoiesis
Ghaffari, S. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2142 · Cited by 376
Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
Oliveri, V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.841814 · Cited by 367
“Cancer cells are characterized by an altered ROS production, compared to normal cells (Trachootham et al., 2009).”
BackgroundKwon, S., Ko, H., You, D. G., Kataoka, K., & Park, J. H. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00136 · Cited by 370
Nagai, M., Vo, N. H., Shin Ogawa, L., Chimmanamada, D., Inoue, T., Chu, J., Beaudette-Zlatanova, B. C., Lu, R., Blackman, R. K., Barsoum, J., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.017 · Cited by 357
A Mitochondria-Targeted Cryptocyanine-Based Photothermogenic Photosensitizer
Jung, H. S., Lee, J.-H., Kim, K., Koo, S., Verwilst, P., Sessler, J. L., Kang, C., & Kim, J. S. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b04263 · Cited by 371
Glutathione-Depleting Nanomedicines for Synergistic Cancer Therapy
Cheng, X., Xu, H.-D., Ran, H.-H., Liang, G., & Wu, F.-G. (2021) · ACS Nano · doi:10.1021/acsnano.1c00498 · Cited by 374
ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors
Halasi, M., Wang, M., Chavan, T. S., Gaponenko, V., Hay, N., & Gartel, A. L. (2013) · Biochemical Journal · doi:10.1042/bj20130282 · Cited by 366
Pei, Q., Hu, X., Zheng, X., Liu, S., Li, Y., Jing, X., & Xie, Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b08219 · Cited by 366
Oxidants, antioxidants and the current incurability of metastatic cancers
Watson, J. (2013) · Open Biology · doi:10.1098/rsob.120144 · Cited by 354
Yang, B., Ding, L., Yao, H., Chen, Y., & Shi, J. (2020) · Advanced Materials · doi:10.1002/adma.201907152 · Cited by 360
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…al. 1991, 1992; Schreck and Baeuerle 1994; Sen and Packer 1996; She et al. 2002; Surh et al. 2005; Surh and Na 2008; Thannickal and Fanburg 2000; Trachootham et al. 2008, 2009; Valko et al. 2007; Weinberg and Chandel 2009; Wondrak 2009; Xiong et al. 2003) and that there are links between NF-jB…”
BackgroundThe independence of and associations among apoptosis, autophagy, and necrosis
Chen, Q., Kang, J., & Fu, C. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0018-5 · Cited by 346
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
Sanders, L. H., & Timothy Greenamyre, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.003 · Cited by 345
“and implicated in aging [9], as well as in a variety of diseases such as cancer [10] and neurological disorders, including Parkinson”
Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2
Liang, J., Cao, R., Wang, X., Zhang, Y., Wang, P., Gao, H., Li, C., Yang, F., Zeng, R., Wei, P., et al. (2017) · Cell Research · doi:10.1038/cr.2016.159 · Cited by 350
xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling
Liu, J., Xia, X., & Huang, P. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.08.021 · Cited by 347
Self-citationMetal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Fusogenic Reactive Oxygen Species Triggered Charge‐Reversal Vector for Effective Gene Delivery
Liu, X., Xiang, J., Zhu, D., Jiang, L., Zhou, Z., Tang, J., Liu, X., Huang, Y., & Shen, Y. (2016) · Advanced Materials · doi:10.1002/adma.201504288 · Cited by 353
Dong, S., Dong, Y., Liu, B., Liu, J., Liu, S., Zhao, Z., Li, W., Tian, B., Zhao, R., He, F., et al. (2022) · Advanced Materials · doi:10.1002/adma.202107054 · Cited by 349
The Potent Oxidant Anticancer Activity of Organoiridium Catalysts
Liu, Z., Romero‐Canelón, I., Qamar, B., Hearn, J. M., Habtemariam, A., Barry, N. P. E., Pizarro, A. M., Clarkson, G. J., & Sadler, P. J. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311161 · Cited by 345
Genetically encoded fluorescent sensors reveal dynamic regulation of NADPH metabolism
Tao, R., Zhao, Y., Chu, H., Wang, A., Zhu, J., Chen, X., Zou, Y., Shi, M., Liu, R., Su, N., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4306 · Cited by 340
Morry, J., Ngamcherdtrakul, W., & Yantasee, W. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.011 · Cited by 333
“All these events will eventually lead to an increase in intracellular ROS production in a positive-feedback manner [54].”
Ye, M., Han, Y., Tang, J., Piao, Y., Liu, X., Zhou, Z., Gao, J., Rao, J., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201702342 · Cited by 338
Selenium: a double-edged sword for defense and offence in cancer
Brozmanová, J., Mániková, D., Vlčková, V., & Chovanec, M. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0595-8 · Cited by 333
“It was suggested that cancer cells normally produce more ROS than do normal cells (Szatrowski and Nathan 1991; Kong et al. 2000; Trachootham et al. 2006, 2009).”
BackgroundRedox-Active Selenium Compounds—From Toxicity and Cell Death to Cancer Treatment
Misra, S., Boylan, M., Selvam, A., Spallholz, J., & Björnstedt, M. (2015) · Nutrients · doi:10.3390/nu7053536 · Cited by 324
“of cancer cells favoring malignancy [16].”
Plasma Medicine: A Field of Applied Redox Biology
VON WOEDTKE, T., SCHMIDT, A., BEKESCHUS, S., WENDE, K., & WELTMANN, K.-D. (2019) · In Vivo · doi:10.21873/invivo.11570 · Cited by 318
Reactive Oxygen Species in Cancer Stem Cells
Shi, X., Zhang, Y., Zheng, J., & Pan, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4529 · Cited by 325
“This aspect has been exploited as an effective approach to selectively kill cancer cells without causing significant toxicity to normal cells (94, 113).”
BackgroundInfluentialNanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy
Qian, X., Zhang, J., Gu, Z., & Chen, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.023 · Cited by 331
Mitochondria and cancer chemoresistance
Guerra, F., Arbini, A. A., & Moro, L. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.012 · Cited by 323
Flavonoids: Antioxidant Powerhouses and Their Role in Nanomedicine
Zahra, M., Abrahamse, H., & George, B. P. (2024) · Antioxidants · doi:10.3390/antiox13080922 · Cited by 250
Metastasis: cancer cell’s escape from oxidative stress
Pani, G., Galeotti, T., & Chiarugi, P. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9225-4 · Cited by 313
“Like in an overhealing wound, CSCs are recruited and activated, migrate out of their niches and begin to make new tissue.”
BackgroundInfluentialReactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment
Chen, X., Song, M., Zhang, B., & Zhang, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1580967 · Cited by 326
“Mitochondrium is a major place to produce intracellular ROS, and complexes I and III of electron transport systems are main sources of mitochondrial O 2 ∙− [2].”
BackgroundPiezoelectric nanocomposites for sonodynamic bacterial elimination and wound healing
Wu, M., Zhang, Z., Liu, Z., Zhang, J., Zhang, Y., Ding, Y., Huang, T., Xiang, D., Wang, Z., Dai, Y., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101104 · Cited by 326
Jin, Y., Lu, Z., Ding, K., Li, J., Du, X., Chen, C., Sun, X., Wu, Y., Zhou, J., & Pan, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3950 · Cited by 322
“Because ROS generation is an important mechanism for certain chemotherapeutic agents to kill tumor cells (30), we next examined whether the niclosamide-induced ROS elevation facilitated its cytotoxicity in AML cells.”
BackgroundHuang, G., Chen, H., Dong, Y., Luo, X., Yu, H., Moore, Z., Bey, E. A., Boothman, D. A., & Gao, J. (2013) · Theranostics · doi:10.7150/thno.5411 · Cited by 318
“Although the increased ROS stress confers mutation advantages in some cases, it also makes the cancer cells more susceptible for ROS-induced toxicity [30].”
BackgroundCobalt nitride nanowire array as an efficient electrochemical sensor for glucose and H2O2 detection
Xie, F., Cao, X., Qu, F., Asiri, A. M., & Sun, X. (2018) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2017.08.098 · Cited by 322
Emerging mechanisms and targeted therapy of ferroptosis in cancer
Wang, H., Cheng, Y., Mao, C., Liu, S., Xiao, D., Huang, J., & Tao, Y. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.022 · Cited by 312
Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism
Allen, B. G., Bhatia, S. K., Anderson, C. M., Eichenberger-Gilmore, J. M., Sibenaller, Z. A., Mapuskar, K. A., Schoenfeld, J. D., Buatti, J. M., Spitz, D. R., & Fath, M. A. (2014) · Redox Biology · doi:10.1016/j.redox.2014.08.002 · Cited by 312
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
Liu, D. S., Duong, C. P., Haupt, S., Montgomery, K. G., House, C. M., Azar, W. J., Pearson, H. B., Fisher, O. M., Read, M., Guerra, G. R., et al. (2017) · Nature Communications · doi:10.1038/ncomms14844 · Cited by 321
Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
YUAN, Y., JIANG, Y.-C., SUN, C.-K., & CHEN, Q.-M. (2016) · Oncology Reports · doi:10.3892/or.2016.4660 · Cited by 320
Targeting apoptosis pathways in cancer by Chinese medicine
Li-Weber, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2010.07.015 · Cited by 318
“reactive oxygen species (ROS), DNA-damaging reagents, and Ca mobilizing stimuli directly or indirectly activate the mitochondrial pathway resulting in the release of cytochrome c and the formation of the apoptosome complex consisting of cytochrome c, Apaf-1 and caspase-9 [4–6].”
BackgroundTitanium-Based Nanoscale Metal–Organic Framework for Type I Photodynamic Therapy
Lan, G., Ni, K., Veroneau, S. S., Feng, X., Nash, G. T., Luo, T., Xu, Z., & Lin, W. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13804 · Cited by 317
The antioxidant paradox: less paradoxical now?
Halliwell, B. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04272.x · Cited by 318
Battogtokh, G., Choi, Y. S., Kang, D. S., Park, S. J., Shim, M. S., Huh, K. M., Cho, Y.-Y., Lee, J. Y., Lee, H. S., & Kang, H. C. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.05.006 · Cited by 310
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Franklin, R. A., Montalto, G., Cervello, M., Libra, M., Candido, S., Malaponte, G., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.659 · Cited by 314
Lim, J. K. M., Delaidelli, A., Minaker, S. W., Zhang, H.-F., Colovic, M., Yang, H., Negri, G. L., von Karstedt, S., Lockwood, W. W., Schaffer, P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821323116 · Cited by 308
“Furthermore, broad evidence now shows that cancer cells that are able to initiate intrinsic antioxidant responses are selected for during tumor progression to cope with oxidative stress arising in response to oncogene activation, accumulation of genetic instability, aberrant metabolism, and mitochondrial dysfunction (…”
BackgroundCancer Stem Cells and Radioresistance: DNA Repair and Beyond
Schulz, A., Meyer, F., Dubrovska, A., & Borgmann, K. (2019) · Cancers · doi:10.3390/cancers11060862 · Cited by 303
“, glutathione, thioredoxin, and enzymatic protein thio edoxin reduct se, dismutase, peroxidase, and catalase, al of which might also shiel the cells against radiation-induced oxidative stress [33].”
BackgroundReactive Species from Cold Atmospheric Plasma: Implications for Cancer Therapy
Graves, D. B. (2014) · Plasma Processes and Polymers · doi:10.1002/ppap.201400068 · Cited by 309
ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy
Dewaele, M., Maes, H., & Agostinis, P. (2010) · Autophagy · doi:10.4161/auto.6.7.12113 · Cited by 306
A historical perspective on porphyrin-based metal–organic frameworks and their applications
Zhang, X., Wasson, M. C., Shayan, M., Berdichevsky, E. K., Ricardo-Noordberg, J., Singh, Z., Papazyan, E. K., Castro, A. J., Marino, P., Ajoyan, Z., et al. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213615 · Cited by 300
The Thioredoxin System as a Therapeutic Target in Human Health and Disease
Mahmood, D. F. D., Abderrazak, A., El Hadri, K., Simmet, T., & Rouis, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4757 · Cited by 305
“Further, H 2 O 2 can also be reduced by anti-oxidants such as glutathione and thioredoxin (Trx) [adapted from (420)].”
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
Delli Bovi, A. P., Marciano, F., Mandato, C., Siano, M. A., Savoia, M., & Vajro, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.595371 · Cited by 289
Exploiting replicative stress to treat cancer
Dobbelstein, M., & Sørensen, C. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4553 · Cited by 302
Krause, M., Dubrovska, A., Linge, A., & Baumann, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.002 · Cited by 305
“The physiological ROS level is maintained by the scavenging molecules such as glutathione, dismutase, peroxidase, thioredoxin, catalase, and superoxide [33].”
BackgroundRecent advances of cancer chemodynamic therapy based on Fenton/Fenton-like chemistry
Cao, C., Wang, X., Yang, N., Song, X., & Dong, X. (2022) · Chemical Science · doi:10.1039/d1sc05482a · Cited by 298
Measuring EGSH and H2O2 with roGFP2-based redox probes
Morgan, B., Sobotta, M. C., & Dick, T. P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.035 · Cited by 293
“Redox changes correlate with many cell fate decisions including proliferation, differentiation, and apoptosis [1], and increased production of reactive oxygen species (ROS) is observed in a large number of diseases, includingmany cancers [2–4].”
BackgroundWang, J., Luo, C., Shan, C., You, Q., Lu, J., Elf, S., Zhou, Y., Wen, Y., Vinkenborg, J. L., Fan, J., et al. (2015) · Nature Chemistry · doi:10.1038/nchem.2381 · Cited by 301
ROS homeostasis and metabolism: a critical liaison for cancer therapy
Kim, J., Kim, J., & Bae, J.-S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.119 · Cited by 293
Excessive mechanical loading promotes osteoarthritis through the gremlin-1–NF-κB pathway
Chang, S. H., Mori, D., Kobayashi, H., Mori, Y., Nakamoto, H., Okada, K., Taniguchi, Y., Sugita, S., Yano, F., Chung, U.-I., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09491-5 · Cited by 293
Zhang, Y., Bai, X., Wang, X., Shiu, K.-K., Zhu, Y., & Jiang, H. (2014) · Analytical Chemistry · doi:10.1021/ac5009699 · Cited by 297
Biosystem‐Inspired Engineering of Nanozymes for Biomedical Applications
Zhang, L., Wang, H., & Qu, X. (2024) · Advanced Materials · doi:10.1002/adma.202211147 · Cited by 297
Molecular and nanoengineering approaches towards activatable cancer immunotherapy
Zhang, C., & Pu, K. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00773c · Cited by 302
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
Aboelella, N. S., Brandle, C., Kim, T., Ding, Z.-C., & Zhou, G. (2021) · Cancers · doi:10.3390/cancers13050986 · Cited by 286
“Although promising results have been observed in some cases, the use of these pro-oxidants for cancer treatment often encounters challenges related to tumor selectivity, toxicity to normal tissues, and development of chemoresistance [7,8,123,124].”
BackgroundRegulation of reactive oxygen species in stem cells and cancer stem cells
Kobayashi, C. I., & Suda, T. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22764 · Cited by 286
“In addition, excess ROS may induce cancer cell death through non-specific oxidation of cellular components or by triggering cell death mechanisms (Trachootham et al., 2009).”
BackgroundHeme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions
Consoli, V., Sorrenti, V., Grosso, S., & Vanella, L. (2021) · Biomolecules · doi:10.3390/biom11040589 · Cited by 284
Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade
Yu, S., Wang, C., Yu, J., Wang, J., Lu, Y., Zhang, Y., Zhang, X., Hu, Q., Sun, W., He, C., et al. (2018) · Advanced Materials · doi:10.1002/adma.201801527 · Cited by 294
Teo, R. D., Hwang, J. Y., Termini, J., Gross, Z., & Gray, H. B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00400 · Cited by 289
The Roles of ROS in Cancer Heterogeneity and Therapy
de Sá Junior, P. L., Câmara, D. A. D., Porcacchia, A. S., Fonseca, P. M. M., Jorge, S. D., Araldi, R. P., & Ferreira, A. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2467940 · Cited by 287
“The previous study demonstrated that preincubation of normal epithelial cells to low but continuous levels of exogenous oxidants confers cellular resistance to subsequent oxidative stress even at higher concentrations, showing that cancer cells may adapt to survive to oxidative microenvironments [102].”
BackgroundInfluentialIn Vitro Reconstitution of Mycobacterial Ergothioneine Biosynthesis
Seebeck, F. P. (2010) · Journal of the American Chemical Society · doi:10.1021/ja101721e · Cited by 291
Charlton, N. C., Mastyugin, M., Török, B., & Török, M. (2023) · Molecules · doi:10.3390/molecules28031057 · Cited by 258
Recent advances in enhanced chemodynamic therapy strategies
Tian, Q., Xue, F., Wang, Y., Cheng, Y., An, L., Yang, S., Chen, X., & Huang, G. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101162 · Cited by 290
Deng, Z., Qian, Y., Yu, Y., Liu, G., Hu, J., Zhang, G., & Liu, S. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04115 · Cited by 288
Upconversion NIR-II fluorophores for mitochondria-targeted cancer imaging and photothermal therapy
Zhou, H., Zeng, X., Li, A., Zhou, W., Tang, L., Hu, W., Fan, Q., Meng, X., Deng, H., Duan, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19945-w · Cited by 287
Strategies for enhancing cancer chemodynamic therapy performance
Jana, D., & Zhao, Y. (2022) · Exploration · doi:10.1002/exp.20210238 · Cited by 284
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Jyotsana, N., Ta, K. T., & DelGiorno, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858462 · Cited by 272
Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms
Matés, J. M., Segura, J. A., Alonso, F. J., & Márquez, J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.07.028 · Cited by 286
Hu, R., Fang, Y., Huo, M., Yao, H., Wang, C., Chen, Y., & Wu, R. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.03.014 · Cited by 284
Li, H.-Y., Zhang, J., Sun, L.-L., Li, B.-H., Gao, H.-L., Xie, T., Zhang, N., & Ye, Z.-M. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.543 · Cited by 284
Shao, D., Zhai, P., Del Re, D. P., Sciarretta, S., Yabuta, N., Nojima, H., Lim, D.-S., Pan, D., & Sadoshima, J. (2014) · Nature Communications · doi:10.1038/ncomms4315 · Cited by 276
Redox regulation in stem-like cancer cells by CD44 variant isoforms
Nagano, O., Okazaki, S., & Saya, H. (2013) · Oncogene · doi:10.1038/onc.2012.638 · Cited by 280
Wang, P., Gong, Q., Hu, J., Li, X., & Zhang, X. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01704 · Cited by 270
Metadata
- Authors
- Trachootham, D., Alexandre, J., & Huang, P.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Huang, Peng
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-05-29
- Volume
- 8
- Issue
- 7
- Pages
- 579-591
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1972779889
- Cited by
- 5,452
- References
- 163
- Citations by year
- 2026: 322 · 2025: 332 · 2024: 340 · 2023: 372 · 2022: 421 · 2021: 462 · 2020: 444 · 2019: 454 · 2018: 393 · 2017: 404 · 2016: 341 · 2015: 289 · 2014: 282 · 2013: 204 · 2012: 158
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA085563, R01CA109041, CA109041, R01CA085563, R01CA100428, CA100428)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- reactive oxygen species, oxidative stress, redox modulation, cancer cells, drug resistance, antioxidant capacity, anticancer agents, genomic instability
- MeSH terms
- Adaptation, Physiological, Animals, Glutathione, Humans, Neoplasms, Oxidation-Reduction, Neoplastic Stem Cells, Reactive Oxygen Species, Drug Resistance, Neoplasm
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.